Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Prevention of First Psychotic Episode - a 2x2-Factorial Randomized Trial Investigating the Efficacy of Acetylcysteine and Integrated Preventive Psychological Intervention in Subjects Clinically at High Risk for Psychosis

NCT03149107 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT03149107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03149107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Prevention of First Psychotic Episode - a 2x2-Factorial Randomized Trial Investigating the Efficacy of Acetylcysteine and Integrated Preventive Psychological Intervention in Subjects Clinically at High Risk for Psychosis
Lead sponsor
University Hospital, Bonn
Phase
Phase 3
Overall status
Terminated
Start date
September 1, 2016
Completion date
January 31, 2021
Enrollment
48 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

prodromal schizophrenia